Document is current
Any future updates will be listed below
-
Authors
Khan, Ajmal
Choi, Boseung
Kang, Seungbae
Weng, Daniel Y.
Ying, Kevin
McElroy, Joseph P.
Kamel, Sahar
Reisinger, Sarah A.
Wewers, Mark D.
Shields, Peter G.
Song, Min-Ae
-
Funding
Funding for this research was provided by:
Ministry of Education (RS- 202300245056)
National Cancer Institute of the National Institutes of Health ((P30 CA016058))
The Food and Drug Administration Center for Tobacco Products ((P50CA180908))
Pelotonia Intramural Research Funds
The Clinical and Translational Science Award ((UM1TR004548))
The National Center for Advancing Translational Sciences ((UL1TR001070))
The Prevent Cancer Foundation
Research start-up from OSU Comprehensive Cancer Center and OSU College of Public Health
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 31 March 2026
First Online: 11 April 2026
Declarations
:
: The study was approved by The OSU Institutional Review Board (OSU-2015C0088) and is registered on Clinicaltrials.gov (NCT02596685; 2015-11-04). Informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.
